Market size, growth to 2033 and clinical trials, side by side.
Germany is the bigger Cannabidiol (CBD) market: $807 Mn against $573 Mn in 2023, about 1.4 times as large.
Germany grows faster: 15% a year, against 14.8%.
Clinical research: 11 active trials in the UK, 11 in Germany.
| Measure | ||
|---|---|---|
| Market size, 2023 | $573 Mn | $807 Mn |
| Market size, 2033 projected | $2.3 Bn | $3.3 Bn |
| Growth a year (CAGR) | 14.8% | 15% |
| Money added, 2023–2033 | $1.7 Bn | $2.5 Bn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $8.25 | $9.67 |
| Active clinical trials | 11 | 11 |
| Full report | UK report | Germany report |
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Germany is the bigger Cannabidiol (CBD) market: $807 Mn against $573 Mn in 2023, about 1.4 times as large.
Germany grows faster: 15% a year, against 14.8%.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.